UNH FY 2014 Earnings Report — UnitedHealth Group Incorporated Revenue & Financial Results | Market Cap Arena

UnitedHealth Group IncorporatedUNH

FY 2014 Earnings

Reported February 10, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$130.5B	—	$122.5B	—	6.5%
Op. Income	$10.3B	—	$9.6B	—	6.8%
Gross Margin	25.6%	—	24.8%	—	0.8pp
Net Margin	4.3%	—	4.6%	—	-0.3pp
EPS (Diluted)	$5.70	—	$5.50	—	3.6%
Free Cash Flow	$6.6B	—	$5.8B	—	13.3%

Revenue Flow

Item	Amount
REVENUE	$130.5B
Cost of Revenue	$97.0B
GROSS PROFIT	$33.4B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$0
Other Expenses	$23.2B
Operating Expenses	$23.2B
Cost & Expenses	$120.2B
OPERATING INCOME	$10.3B
Interest Income	$0
Interest Expense	$618M
Other Income/Expenses	-$618M
INCOME BEFORE TAX	$9.7B
Income Tax Expense	$4.0B
Net Income from Continuing Ops	$5.6B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.6B
D&A	$1.5B
EBIT	$10.3B
EBITDA	$11.8B
EPS	$6
EPS Diluted	$6

Income Statement

Item	Amount
REVENUE	$130.5B
Cost of Revenue	$97.0B
GROSS PROFIT	$33.4B
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$0
Other Expenses	$23.2B
Operating Expenses	$23.2B
Cost & Expenses	$120.2B
OPERATING INCOME	$10.3B
Interest Income	$0
Interest Expense	$618M
Other Income/Expenses	-$618M
INCOME BEFORE TAX	$9.7B
Income Tax Expense	$4.0B
Net Income from Continuing Ops	$5.6B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.6B
D&A	$1.5B
EBIT	$10.3B
EBITDA	$11.8B
EPS	$6
EPS Diluted	$6

Cash Flow Statement

Item	Amount
Net Income	$5.6B
Depreciation & Amortization	$1.5B
Stock-Based Compensation	$364M
Deferred Income Tax	-$415M
Other Non-Cash Items	$0
Change in Working Capital	$1.0B
OPERATING CASH FLOW	$8.1B
Capital Expenditure	-$1.4B
Acquisitions (Net)	-$1.9B
Purchases of Investments	-$9.9B
Sales/Maturities of Investments	$799M
Other Investing Activities	$10.0B
NET CASH FROM INVESTING	-$2.5B
Net Debt Issuance	$391M
Common Stock Repurchased	-$4.0B
Common Dividends Paid	-$1.4B
Other Financing Activities	-$314M
NET CASH FROM FINANCING	-$5.3B
FREE CASH FLOW	$6.6B
Net Change in Cash	$219M

Balance Sheet

Item	Amount
Cash & Equivalents	$7.5B
Short-Term Investments	$1.7B
Net Receivables	$4.3B
Inventory	$0
Other Current Assets	$10.1B
TOTAL CURRENT ASSETS	$23.6B
PP&E (Net)	$4.4B
Goodwill	$32.9B
Intangible Assets	$3.7B
Long-Term Investments	$18.8B
Tax Assets	$556M
Other Non-Current Assets	$2.4B
TOTAL NON-CURRENT ASSETS	$62.8B
TOTAL ASSETS	$86.4B
Account Payables	$21.3B
Short-Term Debt	$1.4B
Deferred Revenue	$2.0B
Other Current Liabilities	$6.0B
TOTAL CURRENT LIABILITIES	$30.6B
Long-Term Debt	$16.0B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.1B
Other Non-Current Liabilities	$3.8B
TOTAL NON-CURRENT LIABILITIES	$21.9B
TOTAL LIABILITIES	$52.5B
Common Stock	$10M
Additional Paid-In Capital	$0
Retained Earnings	$33.8B
Treasury Stock	$0
Accum. Other Comp. Income	-$1.4B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$32.5B
Minority Interest	$1.4B
TOTAL EQUITY	$33.8B
TOTAL LIABILITIES & EQUITY	$86.4B
Total Debt	$17.4B
Net Debt	$9.9B